Oragenics Inc (AMEX:OGEN) has a beta value of 0.39 and has seen 1.08 million shares traded in the last trading session. The company, currently valued at $4.15M, closed the last trade at $0.34 per share which meant it lost -$0.02 on the day or -4.20% during that session. The OGEN stock price is -2176.47% off its 52-week high price of $7.74 and 26.47% above the 52-week low of $0.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.17 million shares traded. The 3-month trading volume is 835.66K shares.

Oragenics Inc (AMEX:OGEN) trade information

Sporting -4.20% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the OGEN stock price touched $0.34 or saw a rise of 27.64%. Year-to-date, Oragenics Inc shares have moved -6.63%, while the 5-day performance has seen it change -12.04%. Over the past 30 days, the shares of Oragenics Inc (AMEX:OGEN) have changed 9.32%. Short interest in the company has seen 0.19 million shares shorted with days to cover at 0.43.

Oragenics Inc (OGEN) estimates and forecasts

The company’s shares have lost -66.06% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 29.34% over the past 5 years.

OGEN Dividends

Oragenics Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Oragenics Inc (AMEX:OGEN)’s Major holders

Insiders own 25.41% of the company shares, while shares held by institutions stand at 11.13% with a share float percentage of 14.92%. Investors are also buoyed by the number of investors in a company, with Oragenics Inc having a total of 21.0 institutions that hold shares in the company.